ONCONOVA THERAPEUTICS INC (ONTX)

US68232V8019 - Common Stock

0.9953  0 (-0.47%)

After market: 0.9012 -0.09 (-9.45%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
237.00K230.00K230.00K230.00K2.18M
Minority Interest Expense
N/AN/AN/AN/AN/A
Operating Expenses
21.80M19.85M16.72M25.22M23.88M
Research and Development
12.77M11.41M7.30M16.90M15.54M
Selling, General, and Administrative Expenses
9.03M8.45M9.43M8.33M8.35M
Operating Income
-21.57M-19.63M-16.50M-24.99M-21.70M
Interest Income/Expense
N/A0.00320.00K-210.00K60.00K
Other Income/Expense
1.38M660.00K10.00K50.00K140.00K
Income Before Taxes
-20.19M-18.96M-16.16M-25.15M-21.49M
Income Tax
N/AN/A0.000.0010.00K
Net Income
-20.19M-18.96M-16.16M-25.16M-21.50M
EBITDA
N/A-19.62M-16.49M-24.98M-21.69M
 
Per Share Data
EPS Diluted Total Ops
-0.97-0.91-0.96-2.17-22.39
Non GAAP EPS
-0.97-0.91-0.94-1.95-45.59
 
Statistics
Profit Margin
-8518.57%-8243.48%-7026.09%-10939.13%-986.24%
Operating Profit Margin
-9100.84%-8534.78%-7173.91%-10865.22%-995.41%

All data in USD

Charts